Siemens Wagers That a Breakup and a Buyback Can Justify Its Premium

Siemens has set in motion the separation of Siemens Healthineers, with the spin-off slated to be completed in 2027. The industrial group announced on 5 November that it intends to deconsolidate the medical-technology unit through a carve-out, and shareholders of both companies will be asked to approve the move at their annual general meetings in February 2027. The renamed entity would trade simply as Healthineers — a change that itself requires the blessing of Siemens Healthineers' own shareholder meeting.

The timing matters. Siemens is asking investors to back a structural overhaul at the same moment it must convince them that its valuation premium is earned rather than assumed. JPMorgan removed the stock from its "Analyst Focus List" yesterday, even as analyst Phil Buller kept an Overweight rating and a EUR 345 price target. Buller now considers the premium justified and expects guidance in line with market expectations — a verdict that argues for fair value but leaves precious little room for disappointment.

The bar is set at "in line"

That is the crux for anyone holding the shares into the upcoming results. Confirmation of expectations may be enough to sustain the current valuation argument; a shortfall would strike at its central premise. The reported figures show where Siemens has been. The outlook must show whether it can meet expectations for where it is going — and with the premium already deemed warranted, that second layer carries more weight than usual.

The operational record offers some support. Siemens agreed yesterday to acquire Lauterbach, a provider of debug and trace solutions for embedded software that generated roughly EUR 60 million in revenue in 2025. The deal broadens the portfolio story in semiconductor design and verification, provided it closes — it remains subject to customary conditions and regulatory approvals, with Siemens expecting completion in the first half of 2027.

Should investors sell immediately? Or is it worth buying Siemens?

Grid, rail and silicon fill out the pipeline

In the power network business, Siemens and Kärnten Netz signed a six-year contract on Monday covering the Gridscale-X platform, which is designed to support planning and management of the electricity grid and to make bottlenecks visible. Rail infrastructure is getting fresh capital as well: on Friday Siemens opened a manufacturing and research centre for rail infrastructure in Chippenham, United Kingdom, an investment of EUR 115 million that the company says safeguards 800 local jobs. The site develops, tests and builds digital signalling technology.

Signalling orders are stacking up further east. Siemens disclosed on 5 November that it will equip the Brown Line and the Green Line extension of Taiwan's Taoyuan metro with signalling technology, with ST Engineering as the customer. Commissioning of the new sections is planned for the mid-2030s — a long horizon that supports the strategic case but does little for near-term earnings.

Closer to home, the buyback continues. Siemens repurchased about 360,000 of its own shares between 2 and 8 November, bringing the total acquired under the programme since 1 July to roughly 5.94 million shares. On the Mobility side, the company completed the acquisition of several key business units of Italy's MERMEC Group on 4 November after all required approvals came through, folding them into Siemens Mobility.

Siemens at a turning point? This analysis reveals what investors need to know now.

What the premium demands

None of this insulates the stock from the expectation hurdle. Should guidance fall short of market forecasts, the valuation premium could come under pressure, and JPMorgan's broadly positive stance offers no protection — that rating rests on expectations Siemens has yet to underwrite with its forthcoming commentary. The gap between strategic announcements and economic delivery is wide: the Lauterbach contribution depends first on closing, and the Taoyuan signalling work stretches well into the next decade. For a near-term re-rating, the more immediate business expectations would need to impress on their own.

A press conference and analyst call will follow the results, and investors will be listening for a coherent thread linking the current business, the strategic projects and the projected trajectory. Confirmation of expectations keeps the existing valuation case intact; a disappointment would weaken its key condition. Extra confidence would only be warranted if Siemens delivers hard operational arguments beyond the growth already priced in.

Ad

Siemens Stock: New Analysis - 11 November

Fresh Siemens information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Siemens analysis...